SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Tenet Healthcare Corp – ‘8-K/A’ for 1/7/21

On:  Tuesday, 3/2/21, at 4:32pm ET   ·   For:  1/7/21   ·   Accession #:  1193125-21-65584   ·   File #:  1-07293

Previous ‘8-K’:  ‘8-K’ on / for 2/9/21   ·   Next & Latest:  ‘8-K’ on / for 4/20/21

Magnifying glass tilted right emoji
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/02/21  Tenet Healthcare Corp             8-K/A:5     1/07/21   11:175K                                   Donnelley … Solutions/FA

Amendment to Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K/A       Amendment to Current Report                         HTML     25K 
 7: R1          Document and Entity Information                     HTML     52K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 6: XML         XBRL Instance -- d121875d8ka_htm                     XML     19K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 3: EX-101.DEF  XBRL Definitions -- thc-20210107_def                 XML     41K 
 4: EX-101.LAB  XBRL Labels -- thc-20210107_lab                      XML     68K 
 5: EX-101.PRE  XBRL Presentations -- thc-20210107_pre               XML     43K 
 2: EX-101.SCH  XBRL Schema -- thc-20210107                          XSD     15K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               14±    22K 
11: ZIP         XBRL Zipped Folder -- 0001193125-21-065584-xbrl      Zip     11K 

‘8-K/A’   —   Amendment to Current Report

This is an HTML Document rendered as filed.  [ Alternative Formats ]

 i TENET HEALTHCARE CORP  i true  i 0000070318 0000070318 2021-01-07 2021-01-07 0000070318 us-gaap:CommonStockMember 2021-01-07 2021-01-07 0000070318 us-gaap:SeniorNotesMember 2021-01-07 2021-01-07





Washington, D.C. 20549



FORM  i 8-K/A


Amendment No. 1




Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report:  i January 7, 2021 (Date of earliest event reported)




(Exact name of Registrant as specified in its charter)




 i Nevada    i 1-7293    i 95-2557091
of Incorporation)
File Number)
  (IRS Employer
Identification Number)

 i 14201 Dallas Parkway

 i Dallas,  i Texas  i 75254

(Address of principal executive offices, including zip code)

 i (469)  i 893-2200

(Registrant’s telephone number, including area code)



Securities registered pursuant to Section 12(b) of the Act:


Title of each class




Name of each exchange
on which registered

 i Common stock, $0.05 par value    i THC    i New York Stock Exchange
 i 6.875% Senior Notes due 2031    i THC31    i New York Stock Exchange

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:



Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)



Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)



Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))



Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging Growth Company  i 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ☐




Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 i On January 8, 2021, Tenet Healthcare Corporation (the “Company”) filed a Current Report on Form 8-K (the “Original Report”) to report that the Company’s Board of Directors (the “Board”) appointed Admiral Cecil D. Haney to the Board, effective on January 7, 2021. Admiral Haney had not yet been appointed to serve on any committees of the Board as of the Original Report. The Company is filing this amendment to the Original Report to report that, on February 24, 2021, the Board appointed Admiral Haney to serve as a member of the Board’s Audit Committee and Nominating and Corporate Governance Committee, effective immediately.


Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Date: March 2, 2021      

/s/ Audrey Andrews

    Name:   Audrey Andrews

Executive Vice President, General Counsel and

Corporate Secretary

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K/A’ Filing    Date    Other Filings
Filed on:3/2/21
For Period end:1/7/213,  8-K
 List all Filings 
Filing Submission 0001193125-21-065584   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2021 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Apr. 22, 3:59:05.0pm ET